Document is current
Any future updates will be listed below
-
Authors
García-Porrúa, Carlos https://orcid.org/0009-0001-4933-957X
Pinto Tasende, José Antonio https://orcid.org/0000-0002-4993-8185
Cervantes Pérez, Evelin Cecilia https://orcid.org/0000-0001-8108-6157
Melero-González, Rafael Benito https://orcid.org/0000-0002-7967-351X
Maceiras-Pan, Francisco José https://orcid.org/0000-0003-4527-3056
-
Funding
Funding for this research was provided by:
UCB España (Medical writing assistance)
UCB España (Medical writing assistance)
UCB España (Medical writing assistance)
UCB España (Medical writing assistance)
UCB España (Medical writing assistance)
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 8 June 2026
First Online: 17 June 2026
Declarations
:
: Not applicable.
: Not applicable.
: JPT has received consulting and advisory boards fees and research grants from Bristol Myers Squibb, Celgene, AbbVie, Janssen, Novartis, Pfizer, and UCB. CG-P, ECP, RM-G, and FMP declare no conflicts of interest.
